11/21
12:32 pm
pbyi
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer [Yahoo! Finance]
Low
Report
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer [Yahoo! Finance]
11/20
11:38 am
pbyi
Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
11/20
09:03 am
pbyi
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer [Yahoo! Finance]
Low
Report
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer [Yahoo! Finance]
11/20
08:57 am
pbyi
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Medium
Report
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
11/14
07:09 am
pbyi
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative [Yahoo! Finance]
Low
Report
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative [Yahoo! Finance]
11/11
11:13 pm
pbyi
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Medium
Report
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
11/9
09:28 am
pbyi
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
High
Report
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/8
12:31 pm
pbyi
Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
11/8
11:57 am
pbyi
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up [Yahoo! Finance]
Medium
Report
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up [Yahoo! Finance]
11/8
02:48 am
pbyi
Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
High
Report
Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
11/7
04:05 pm
pbyi
Puma Biotechnology Reports Third Quarter 2024 Financial Results
Medium
Report
Puma Biotechnology Reports Third Quarter 2024 Financial Results
11/5
05:15 pm
pbyi
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
11/1
02:04 am
pbyi
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
10/29
08:30 am
pbyi
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ: PBYI) and Encourages Investors to Contact the Firm
Medium
Report
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ: PBYI) and Encourages Investors to Contact the Firm
10/24
04:07 pm
pbyi
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
Medium
Report
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
10/23
11:07 pm
pbyi
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Neutral
Report
Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
10/13
10:33 am
pbyi
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? [Yahoo! Finance]
Low
Report
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? [Yahoo! Finance]
9/16
06:47 am
pbyi
Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago [Yahoo! Finance]
Low
Report
Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago [Yahoo! Finance]
9/3
04:15 pm
pbyi
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference